# In Silico Identification and Molecular Characterization of Lentilactobacillus hilgardii Antimicrobial Peptides with Activity Against Carbapenem-Resistant Acinetobacter baumannii

**Authors:** Amanda Appel, Lily Velazco, Adit B. Alreja, Kara LeClair, Aryaan P. Duggal, Isha Vashee, Aji Mary Taal, Norberto Gonzalez-Juarbe, Derrick E. Fouts

PMC · DOI: 10.3390/antibiotics14101004 · Antibiotics · 2025-10-10

## TL;DR

This study identifies antimicrobial peptides from lactic acid bacteria that can disrupt biofilms of a drug-resistant bacteria and work well with existing antibiotics.

## Contribution

A novel platform for discovering antimicrobial peptides from commensal bacteria and demonstrating their synergy with antibiotics against biofilms.

## Key findings

- Five LAB species significantly inhibited Acinetobacter baumannii biofilm formation and reduced mature biofilm biomass.
- AMPs from L. hilgardii synergized with meropenem to decolonize A. baumannii biofilms.
- LAB-conditioned media showed broad-spectrum activity against ESKAPE pathogens but varied effects on commensals.

## Abstract

Background/Objectives: Biofilm formation by Acinetobacter baumannii contributes to its persistence in clinical settings and resistance to antibiotic treatment. This study aims to identify and characterize antimicrobials from lactic acid bacteria (LAB) using molecular and in silico approaches that can prevent and disrupt A. baumannii biofilms, assess their antimicrobial host range, and define their synergy with current antibiotics. Methods: Thirteen LAB isolates from the Human Microbiome Project were screened for anti-biofilm activity against A. baumannii. Conditioned media was further tested against six ESKAPE pathogens and three skin commensals. Lentilactobacillus hilgardii was selected for detailed study and antimicrobial peptide (AMP) prediction analysis due to limited toxicity toward commensals. In silico identified peptides were synthesized and tested individually and in combination with sub-MIC doses of an antibiotic. Results: Conditioned media from five LAB species (Lentilactobacillus hilgardii, Lentilactobacillus buchneri, Ligilactobacillus ruminis, Limosilactobacillus fermentum, and Limosilactobacillus antri) significantly inhibited A. baumannii biofilm formation and reduced biomass of mature biofilms. LAB-conditioned media also exhibited broad-spectrum activity against ESKAPE pathogens, though effects on commensals varied. Bioinformatically predicted AMPs from L. hilgardii inhibited planktonic A. baumannii growth but showed no direct biofilm activity even at high doses. However, AMPs were found to synergize with sub-MIC doses of meropenem against mature biofilms leading to decolonization. Conclusions: Our study provides a comprehensive platform for the discovery and characterization of AMPs and supports using commensal bacteria to reduce, prevent, and decolonize biofilms from pathogenic bacteria in community and nosocomial settings.

## Linked entities

- **Chemicals:** meropenem (PubChem CID 441130)
- **Species:** Lentilactobacillus hilgardii (taxon 1588), Lentilactobacillus buchneri (taxon 1581), Ligilactobacillus ruminis (taxon 1623), Limosilactobacillus fermentum (taxon 1613), Limosilactobacillus antri (taxon 227943), Acinetobacter baumannii (taxon 470)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420)
- **Chemicals:** AMPs (MESH:C014308), meropenem (MESH:D000077731), Carbapenem (MESH:D015780), AMP (MESH:D000089882)
- **Species:** Lentilactobacillus hilgardii (species) [taxon 1588], Acinetobacter baumannii (species) [taxon 470], Leptospira sp. AB (species) [taxon 103236], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12561633/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12561633/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12561633/full.md

---
Source: https://tomesphere.com/paper/PMC12561633